Holen Sie sich die Stockscreener-App
1.70
0.00%
0.00
Handel nachbörslich:
1.70
Schlusskurs vom Vortag:
$1.70
Offen:
$1.71
24-Stunden-Volumen:
420.95K
Relative Volume:
0.61
Marktkapitalisierung:
$173.47M
Einnahmen:
$447.48M
Nettoeinkommen (Verlust:
$-14.55M
KGV:
-17.00
EPS:
-0.1
Netto-Cashflow:
$7.61M
1W Leistung:
-14.14%
1M Leistung:
-10.05%
6M Leistung:
+4.29%
1J Leistung:
-33.85%
1-Tages-Spanne:
$1.69
$1.745
1-Wochen-Bereich:
$1.69
$1.965
52-Wochen-Spanne:
$1.40
$3.05
Accuray Inc Stock (ARAY) Company Profile
Firmenname
Accuray Inc
Sektor
Branche
Telefon
608-824-2800
Adresse
1240 DEMING WAY, MADISON, CA
Vergleichen Sie ARAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| ARAY | 1.70 | 173.47M | 447.48M | -14.55M | 7.61M | -0.10 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-12-22 | Eingeleitet | Loop Capital | Buy |
| 2020-01-21 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-11-01 | Hochstufung | Citigroup | Sell → Neutral |
| 2017-12-13 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-11-30 | Eingeleitet | Lake Street | Buy |
| 2016-12-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2015-12-22 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2015-11-12 | Eingeleitet | Citigroup | Sell |
| 2015-05-01 | Bestätigt | Dougherty & Company | Buy |
| 2015-01-12 | Eingeleitet | Northland Capital | Outperform |
| 2014-01-31 | Bestätigt | Dougherty & Company | Buy |
| 2014-01-29 | Bestätigt | Brean Capital | Buy |
| 2013-11-11 | Bestätigt | Dougherty & Company | Buy |
| 2013-08-29 | Bestätigt | Dougherty & Company | Buy |
| 2011-09-20 | Bestätigt | Ticonderoga | Buy |
| 2010-02-08 | Hochstufung | Jefferies & Co | Hold → Buy |
| 2009-12-09 | Hochstufung | UBS | Sell → Neutral |
| 2009-03-09 | Herabstufung | Soleil | Buy → Hold |
| 2009-01-30 | Hochstufung | Piper Jaffray | Neutral → Buy |
| 2008-12-22 | Bestätigt | Jefferies & Co | Hold |
| 2008-08-20 | Bestätigt | Jefferies & Co | Hold |
Alle ansehen
Accuray Inc Aktie (ARAY) Neueste Nachrichten
Accuray (NASDAQ:ARAY) Rating Lowered to "Hold" at StockNews.com - MarketBeat
Bridging Gaps and Making Precision Oncology Accessible Across India with Accuray - Elets
Accuray (NASDAQ:ARAY) Stock Rating Upgraded by StockNews.com - Defense World
Oncology Information Systems Market May See a Big Move| Accuray, Varian Medical Systems, DOSIsoft, ViewRay - openPR
Accuray Incorporated (NASDAQ:ARAY) Q1 2025 Earnings Call Transcript - Insider Monkey
Radiation Therapy Equipment Market Dynamics and Strategies - openPR
Accuray Q1 Earnings Meet Estimates, Sales Beat, Gross Margin Shrinks - Yahoo Finance
Accuray Inc (ARAY) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth Initiatives - GuruFocus.com
Accuray Inc (ARAY) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance
Accuray Incorporated Reports Strong Start to Fiscal 2025 - TipRanks
Accuray (ARAY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Accuray (ARAY) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Accuray: Fiscal Q1 Earnings Snapshot - San Francisco Chronicle
Accuray Inc (ARAY) Q1 FY2025 Earnings: Revenue Surpasses Estimat - GuruFocus.com
Accuray Inc. Optimistic Despite Revenue Decline - TipRanks
Accuray earnings beat by $0.01, revenue topped estimates - Investing.com UK
Accuray Q1 Earnings Miss: Revenue Slips to $101.5M, Net Loss Widens Amid Product Sales Drop | ARAY Stock News - StockTitan
Accuray (NASDAQ:ARAY) Shares Cross Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Brain Cancer Treatment Industry Set to Flourish Key Regions - openPR
Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024 - StockTitan
Accuray Appoints Michael Murphy as VP Corporate Controller - TipRanks
Accuray Appoints Michael Murphy as VP, Corporate Controller - StockTitan
Comparing enVVeno Medical (NASDAQ:NVNO) and Accuray (NASDAQ:ARAY) - Defense World
Here's Why You Should Retain Accuray Stock in Your Portfolio Now - MSN
New England Journal of Medicine Study Reaffirms Five Session Radiation Treatment Provides Comparable Rates of Cancer Control, Tolerability and Sexual Functioning to Conventional Radiotherapy Treatment in Men with Localized Prostate Cancer - PR Newswire
Philippines Radiotherapy Market to See Booming Growth - openPR
Financial Metrics Unveiled: Accuray Inc (ARAY)’s Key Ratios in the Spotlight - The Dwinnex
Lung Cancer Surgery Market: Detailed Analysis Of Growth Factors - openPR
Accuray CEO Suzanne Winter resumes role after leave By Investing.com - Investing.com Canada
Accuray CEO Returns from Medical Leave - MarketWatch
Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence - PR Newswire
Orthopedic Surgical Robot Market is Projected to Reach a Valuation of US$ 8.34 Billion at a CAGR of 13.5% by 2034 | Fact.MR Report - GlobeNewswire Inc.
Accuray Welcomes Back CEO Suzanne Winter for Growth - TipRanks
Radiotherapy Device Market is Likely to Upsurge at USD 25.16 Bn- Varian Medical Systems, Elekta AB, Accuray, Inc., C.R. Bard, Inc., IBA – IndiaPolitics.com - IndiaPolitics.com
Here's Why You Should Retain Accuray (ARAY) Stock for Now - MSN
Radiotherapy Device Market is Likely to Upsurge at USD 25.16 Bn- Varian Medical Systems, Elekta AB, Accuray, Inc., C.R. Bard, Inc., IBA – KnowCasino - KnowCasino
Dimensional Fund Advisors LP Cuts Stock Position in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Dimensional Fund Advisors LP Has $2.46 Million Holdings in Accuray Incorporated (NASDAQ:ARAY) - MarketBeat
Accuray Inc [NASDAQ: ARAY] Sees Increase in Stock Value - Knox Daily
What is Accuray Inc (ARAY) Stock Return on Shareholders’ Capital? - SETE News
Medical Robot Market Gain Momentum with Major Giants Medtronic, Stryker, Accuray, Omnicell - EIN News
Ablation Technology Market Growth Report | Accuray, Biosense, Corporation, Webster, Smith & Nephew, Varian Medical Systems, Olympus Corporation – Times-BD24 - Times-BD24
Accuray Inc (ARAY) shows promising results - US Post News
Accuray Inc (ARAY) receives a Buy rating from ROTH MKM - Knox Daily
Intelligent Automation in Healthcare Industry Growing Massively – Siemens, General Electric, Accuray - Elektrotransports.lv
AI-based Surgical Robots Market 2024 Global Future Forecasts | Accuray Incorporated, Hansen Medical, Intuitive Surgical, Inc. – Cauverynews - Cauverynews
A closer look at Accuray Inc (ARAY) is warranted - US Post News
Accuray Inc [ARAY] Records 50-Day SMA of $1.9142 - Knox Daily
It is Poised to be a Bull Market for Accuray Inc (ARAY) - SETE News
Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife® S7™ System Medical Professional Training - PR Newswire
500,000 Shares in Accuray Incorporated (NASDAQ:ARAY) Bought by Armistice Capital LLC - Defense World
Finanzdaten der Accuray Inc-Aktie (ARAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):